Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
309M
-
Number of holders
-
107
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
+27.7M
-
Total reported value, excl. options
-
$662M
-
Value change
-
+$234M
-
Put/Call ratio
-
0.66
-
Number of buys
-
71
-
Number of sells
-
-35
-
Price
-
$8.32
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2014
138 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share as of Q4 2014.
AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) has 107 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 309M outstanding shares and own 25.75% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (14.4M shares), Redmile Group, LLC (6.88M shares), NEA Management Company, LLC (5.65M shares), Sectoral Asset Management Inc (4.77M shares), MILLENNIUM MANAGEMENT LLC (3.59M shares), D. E. Shaw & Co., Inc. (3.06M shares), RS INVESTMENT MANAGEMENT CO LLC (2.85M shares), venBio Select Advisor LLC (2.82M shares), VANGUARD GROUP INC (2.38M shares), and Citadel Advisors LLC (2.35M shares).
This table shows the top 107 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.